2025. Real-World Clinical Outcomes of Ujvira® (Trastuzumab Emtansine Biosimilar) in HER2-Positive Breast Cancer: A Retrospective Observational Study in Indian Patients. Journal of Cancer Research Updates. 14, (Aug. 2025), 114–120. DOI:https://doi.org/10.30683/1929-2279.2025.14.13.